Compounds > iclaprim
Page last updated: 2024-09-05

iclaprim and Atypical Mycobacterial Infection, Disseminated

iclaprim has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chew, KL; Octavia, S; Teo, JWP; Yeoh, SF1

Other Studies

1 other study(ies) available for iclaprim and Atypical Mycobacterial Infection, Disseminated

ArticleYear
MIC Values of Iclaprim and Lefamulin against Mycobacterium abscessus Complex.
    Antimicrobial agents and chemotherapy, 2021, 09-17, Volume: 65, Issue:10

    Topics: Anti-Bacterial Agents; Diterpenes; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Polycyclic Compounds; Pyrimidines; Thioglycolates

2021